Works by Hawa, Gerhard


Results: 8
    1
    2
    3

    Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis.

    Published in:
    Hematology, 2019, v. 24, n. 1, p. 318, doi. 10.1080/16078454.2019.1570617
    By:
    • Voskaridou, Ersi;
    • Ntanasis-Stathopoulos, Ioannis;
    • Christoulas, Dimitrios;
    • Sonnleitner, Linda;
    • Papaefstathiou, Athanasios;
    • Dimopoulou, Maria;
    • Missbichler, Albert;
    • Kanellias, Nikolaos;
    • Repa, Konstantina;
    • Papatheodorou, Athanasios;
    • Peppa, Melpomeni;
    • Hawa, Gerhard;
    • Terpos, Evangelos
    Publication type:
    Article
    4

    Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis.

    Published in:
    Hematology, 2019, v. 24, n. 1, p. 318, doi. 10.1080/16078454.2019.1570617
    By:
    • Voskaridou, Ersi;
    • Ntanasis-Stathopoulos, Ioannis;
    • Christoulas, Dimitrios;
    • Sonnleitner, Linda;
    • Papaefstathiou, Athanasios;
    • Dimopoulou, Maria;
    • Missbichler, Albert;
    • Kanellias, Nikolaos;
    • Repa, Konstantina;
    • Papatheodorou, Athanasios;
    • Peppa, Melpomeni;
    • Hawa, Gerhard;
    • Terpos, Evangelos
    Publication type:
    Article
    5

    The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.

    Published in:
    Nephrology Dialysis Transplantation, 2008, v. 23, n. 10, p. 3263, doi. 10.1093/ndt/gfn226
    By:
    • Rukshana C. Shroff;
    • Vanita Shah;
    • Melanie P. Hiorns;
    • Michael Schoppet;
    • Lorenz C. Hofbauer;
    • Gerhard Hawa;
    • Leon J. Schurgers;
    • Atul Singhal;
    • Ian Merryweather;
    • Paul Brogan;
    • Catherine Shanahan;
    • John Deanfield;
    • Lesley Rees
    Publication type:
    Article
    6
    7
    8